Evidence map›Paper›PMID 25371374›Full record

ArticleGenetic epidemiology2015

Genetic simulation tools for post-genome wide association studies of complex diseases.

Huann-Sheng Chen, Carolyn M Hutter, Leah E Mechanic, Christopher I Amos, Vineet Bafna, Elizabeth R Hauser, Ryan D Hernandez, Chun Li, David A Liberles, Kimberly McAllister and 9 more

Abstract read
In one paragraph

Article in Genetic epidemiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. GESDB: a platform of simulation resources for genetic epidemiology studies.Database : the journal of biological databases and curation · 2016
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Huann-Sheng Chen *Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, MD 20892.
Carolyn M Hutter *Division of Genomic Medicine, National Human Genome Research Institute, NIH, Bethesda, MD 20892.
Leah E Mechanic *Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, MD 20892.
Christopher I AmosDivision of Community, Family Medicine, Dartmouth College, Lebanon, NH 03755.
Vineet BafnaDepartment of Computer Science and Engineering, University of California, San Diego, La Jolla, CA 92093.
Elizabeth R HauserDuke Molecular Physiology Institute, Duke University, Durham, NC 27710.
Ryan D HernandezDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143.
Chun LiDepartment of Biostatistics, Vanderbilt University, Nashville, TN 37235.
David A LiberlesDepartment of Molecular Biology, University of Wyoming, Laramie, WY 82071.
Kimberly McAllisterSusceptibility and Population Health Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709.
Jason H MooreDepartment of Genetics, Dartmouth College, Lebanon, NH 03755.
Dina N PaltooOffice of Director, National Institutes of Health, Bethesda, MD 20892.
George J PapanicolaouDivision of Cardiovascular Sciences, Prevention and Population Sciences Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.
Bo PengDepartment of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Marylyn D RitchieDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA 16802.
Gabriel RosenfeldSurveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, MD 20892.
John S WitteDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA 94107.
Elizabeth M Gillanders *Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, MD 20892.
Eric J Feuer *Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, MD 20892.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS Z99 ES999999NCI NIH HHS P30 CA023108
6 · The paper itself

Abstract

Genetic simulation programs are used to model data under specified assumptions to facilitate the understanding and study of complex genetic systems. Standardized data sets generated using genetic simulation are essential for the development and application of novel analytical tools in genetic epidemiology studies. With continuing advances in high-throughput genomic technologies and generation and analysis of larger, more complex data sets, there is a need for updating current approaches in genetic simulation modeling. To provide a forum to address current and emerging challenges in this area, the National Cancer Institute (NCI) sponsored a workshop, entitled "Genetic Simulation Tools for Post-Genome Wide Association Studies of Complex Diseases" at the National Institutes of Health (NIH) in Bethesda, Maryland on March 11-12, 2014. The goals of the workshop were to (1) identify opportunities, challenges, and resource needs for the development and application of genetic simulation models; (2) improve the integration of tools for modeling and analysis of simulated data; and (3) foster collaborations to facilitate development and applications of genetic simulation. During the course of the meeting, the group identified challenges and opportunities for the science of simulation, software and methods development, and collaboration. This paper summarizes key discussions at the meeting, and highlights important challenges and opportunities to advance the field of genetic simulation.

Indexed as

Computer SimulationModels, GeneticSoftwareDiseaseGenome-Wide Association StudyGenomicsHumansMolecular Epidemiologycomplex phenotypescomputational resourcesgenetic simulationnext-generation sequencingrare variants

Identifiers

PMID25371374
PMCPMC4270837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.